Anteris Technologies Global Corp. (ASX:AVR)
Australia · Delayed Price · Currency is AUD 9.05
+0.25 (2.84%)
At close: Mar 3, 2026
ASX:AVR Market Cap
ASX:AVR has a market cap or net worth of 879.95 million as of March 3, 2026. Its market cap has increased by 95.44% in one year.
Market Cap
879.95M
Enterprise Value
865.03M
Revenue
2.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.05
Market Cap Chart
Since June 27, 2011, ASX:AVR's market cap has increased from 985.19K to 879.95M, an increase of 89,217.99%. That is a compound annual growth rate of 58.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 879.95M | 176.46% |
| Dec 31, 2025 | 318.29M | 7.09% |
| Dec 31, 2024 | 297.22M | -12.90% |
| Dec 29, 2023 | 341.26M | 10.57% |
| Dec 30, 2022 | 308.62M | 114.65% |
| Dec 31, 2021 | 143.78M | 548.70% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 12.60B |
| 4DMedical | 2.41B |
| PolyNovo | 625.21M |
| Lumos Diagnostics Holdings | 234.00M |
| Aroa Biosurgery | 210.74M |
| EMVision Medical Devices | 163.57M |
| SomnoMed | 150.73M |
| Cleo Diagnostics | 76.64M |